Interestingly, not only AML, but also the AML-related myeloid neoplasia Myelodysplastic syndromes (MDS) overexpress PRLR on the cell surface, observing a wide range of expression levels, at a comparable frequency rate (AML: 32.278 ± 3.591%; MDS: 32.947 ± 3.708%). The gene discussed is PRLR; the disease is myelodysplastic syndrome.